Primary Effusion Lymphoma: Clinical Trials

1 trial for Primary Effusion Lymphoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable1Completed 1

Follow Primary Effusion Lymphoma: new trials by email Literature Review of Primary Effusion Lymphoma trials Research Report on Primary Effusion Lymphoma

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Salvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin Lymphoma
Laboratory Biomarker Analysis, Quality-of-Life Assessment, Questionnaire Administration - Adult Nasal Type Extranodal NK/T-Cell Lymphoma, Adult T-Cell Leukemia/Lymphoma
Not applicableCompletedMayo Clinic292016-01-192019-11-15

Narrower conditions

Blastic Plasmacytoid Dendritic Cell Neoplasm (1)  ·  Burkitt Lymphoma (1)  ·  Enteropathy-Associated T-Cell Lymphoma (1)  ·  Immunoblastic Lymphadenopathy (1)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (1)  ·  Lymphoma (1)  ·  Lymphoma, B-Cell, Marginal Zone (1)  ·  Lymphoma, Extranodal NK-T-Cell (1)  ·  Lymphoma, Follicular (1)  ·  Lymphoma, Large B-Cell, Diffuse (1)  ·  Lymphoma, Large-Cell, Anaplastic (1)  ·  Lymphoma, Mantle-Cell (1)  ·  Lymphoma, Primary Cutaneous Anaplastic Large Cell (1)  ·  Lymphoma, Primary Effusion (1)  ·  Lymphoma, T-Cell (1)

Broader conditions

Chronic Disease (1)  ·  DNA Virus Infections (1)  ·  Disease Attributes (1)  ·  Epstein-Barr Virus Infections (1)  ·  Hematologic Diseases (1)  ·  Hematologic Neoplasms (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Herpesviridae Infections (1)  ·  Histiocytic Disorders, Malignant (1)  ·  Immune System Diseases (1)  ·  Immunoproliferative Disorders (1)  ·  Infections (1)  ·  Leukemia (1)  ·  Leukemia, B-Cell (1)  ·  Leukemia, Lymphoid (1)

Interventions

Salvia hispanica seed extract (1)

Sponsors

Mayo Clinic (1)

Countries

United States (1)

Top investigators

Thomas Witzig (1)

NIH funding

P30CA015083 (1)